News

Public · Published

From banking to defence: ICICI Direct's 10 stock bets for the year ahead

ICICI Direct assigned Buy ratings to 10 stocks for the year ahead, spanning banking, pharmaceuticals, ports, defence, chemicals and consumption. It cited possible earnings drivers including bank margin recovery, specialist product launches, infrastructure spending and digital business growth; the supplied article excerpt gives Kotak Mahindra Bank a Rs 540 target price.

Published:

Updated:

What happened

ICICI Direct assigned Buy ratings to 10 stocks for the year ahead, spanning banking, pharmaceuticals, ports, defence, chemicals and consumption. It cited possible earnings drivers including bank margin recovery, specialist product launches, infrastructure spending and digital business growth; the supplied article excerpt gives Kotak Mahindra Bank a Rs 540 target price.

Confirmed

Global impact / market context

The picks identify where the brokerage expects company earnings to improve, which can influence investor demand for those shares. For Kotak, lending growth and a shift toward loans and higher-yielding retail products could lift revenue, while healthy asset quality may help limit costs if growth continues.

Analyst inference

The article frames Indian equities as entering Samvat 2083 amid an uncertain economic outlook, making earnings growth a key concern. Its selections span several industries rather than one theme, but the excerpt provides detailed reasoning and a target only for Kotak and part of Venus Pipes.

Confirmed

What to watch

  1. Check whether Kotak’s margins recover as expected, including whether surplus FCNR(B) funds are deployed into loans and lending rates adjust; these changes affect income from lending. Analyst inference
  2. Compare Kotak’s reported advances growth with the brokerage’s 20–22 percent expectation for FY27–28, while tracking asset quality and credit costs for signs of rising loan losses. Analyst inference
  3. The brokerage expects Anup Saha to become Kotak’s MD and CEO from January 2027, a planned leadership change investors can assess for continuity and execution. Confirmed

Evidence

  • Original source link unavailable